# Boston Scientific

its LUX-Dx insertable cardiac monitor line has cleared multiple FDA 510(k)s, though the company issued an FDA recall in 2026 addressing a LUX-Dx II monitoring-system malfunction.

Source: https://en.bioecon.ru/companies/boston-scientific/
Updated: 2026-07-20

- Country: United States
- Ticker: BSX

## Technologies

- [Implantable biosensors for chronic disease](https://en.bioecon.ru/technology/implantable-biosensors-chronic-disease/)